Array Biopharma has announced it is cutting 20% of its staff, following a decision by Amgen to end

GlaxoSmithKline has launched a US $50 million venture capital fund to invest in companies that pioneer bioelectronic medicines

Novartis has reported that phase 3 clinical trial results show that Afinitor did not extend overall survival compared

The US FDA’s Cardiovascular and Renal Drugs Advisory Committee has decided to recommend approval of Bayer’s lung drug,

UK’s National Institute for Health and Care Excellance (NICE) has issued draft guidance stating that advanced breast cancer

Bayer Healthcare’s pulmonary hypertension drug, riociguat, has received a favourable review ahead of the US FDA’s Cardiovascular and

India’s Intellectual Property Appellate Board (IPAB) has revoked the patent for global pharmaceutical company, GlaxoSmithKline’s anti-cancer drug Tykerb.

Roche has announced it is increasing access to a key drug to treat blindness in patients with HIV

GlaxoSmithKline’s approval review date for its diabetes drug has been pushed back by three months by the US